Compugen (CGEN) Cash & Current Investments (2009 - 2026)
Compugen (CGEN) reported Cash & Current Investments of $91.8 million for Q1 2026, up 29.13% on a YoY basis from $71.1 million in Q1 2025, and down 32.71% sequentially from $136.4 million in Q4 2025.
Compugen (CGEN) Cash & Current Investments (2009 - 2026) Analysis & Trends
Compugen (CGEN) has 18 years of Cash & Current Investments data on file, last reported at $91.8 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments rose 29.13% year-over-year to $91.8 million; the trailing twelve-month figure through Mar 2026 stood at $91.8 million (up 29.13% YoY), and the FY2025 full-year result was $136.4 million, up 71.25% from the prior year.
- Cash & Current Investments slipped to $91.8 million in Q1 2026, from $136.4 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $136.4 million in Q4 2025 to a low of $362000.0 in Q4 2022.
- A 5-year average of $72.2 million and a median of $71.1 million in 2025 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments plunged 99.69% in 2022 and jumped 10657.73% in 2023, its largest moves.
- Tracing CGEN's Cash & Current Investments over 5 years: stood at $362000.0 in 2022, then jumped by 10657.73% to $38.9 million in 2023, then surged by 104.47% to $79.6 million in 2024, then soared by 71.25% to $136.4 million in 2025, then plunged by 32.71% to $91.8 million in 2026.
- Business Quant data shows CGEN's Cash & Current Investments at $91.8 million in Q1 2026, $136.4 million in Q4 2025, and $59.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 283.54 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 8.75 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 5.18 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Compugen | 224.57 Mn | 132.82 Mn | 352,000.00 | 91.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.75 Mn |
| Dec 31, 2025 | 136.36 Mn |
| Sep 30, 2025 | 59.36 Mn |
| Jun 30, 2025 | 65.00 Mn |
| Mar 31, 2025 | 71.06 Mn |
| Dec 31, 2024 | 79.63 Mn |
| Sep 30, 2024 | 79.57 Mn |
| Jun 30, 2024 | 59.32 Mn |
| Mar 31, 2024 | 69.05 Mn |
| Dec 31, 2023 | 38.94 Mn |
| Sep 30, 2023 | 47.78 Mn |
| Jun 30, 2023 | 61.98 Mn |
| Mar 31, 2023 | 74.32 Mn |
| Dec 31, 2022 | 362,000.00 |
| Sep 30, 2022 | 88.21 Mn |
| Jun 30, 2022 | 97.29 Mn |
| Mar 31, 2022 | 106.82 Mn |
| Dec 31, 2021 | 117.05 Mn |
| Sep 30, 2021 | 102.25 Mn |
| Jun 30, 2021 | 111.09 Mn |